Live Breaking News & Updates on Vifor Pharma Ag Stock Exchange

Stay updated with breaking news from Vifor pharma ag stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cancellation of remaining publicly held registered shares of Vifor Pharma AG

Last trading day of Vifor registered shares: 22 December 2022

Delisting date of Vifor registered shares: 23 December 2022
. | December 14, 2022 ....

Schweizerisches Handelsamtsblatt , Exchange Regulation , Swiss Exchange , Court St , Fresenius Medical Care , Regulatory News , Commercial Court , Swiss Official Gazette , Vifor Shares , Vifor Fresenius Medical Care Renal Pharma , Vifor Pharma Ag Stock Exchange , Press Release , Ecember Vifn Ch0364749348 ,

Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients

China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1

Approval may also benefit the Chinese healthcare system, among others through implementation. | November 28, 2022 ....

United Kingdom , Coll Cardiol , Yang Weiping , Fresenius Kabi , Acta Cardiol , J Clin Nutr , Clin Dermatol , Australian Longitudinal Study On Women Health , China National Health Commission , National Reimbursement Drug List , China National Medical Products Administration , Public Health Nutr , World Health Organization , Fresenius Medical Care , Regulatory News , National Medical Products Administration , General Manager , Vifor Fresenius Medical Care Renal Pharma , Patient Blood Management , Public Health , Australian Longitudinal Study , Equal Life , Ann Surg , British Journal , Blood Transfus , Vifor Pharma Ag Stock Exchange ,

Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Committee for Medicinal Products for Human Use recommends approval of Kapruvia® as first therapy in Europe for the treatment of chronic kidney. | February 28, 2022 ....

United States , Christopher Posner , Vifor Pharma , Klaus Henning Jensen , International Journal Of Nephrology , Cara Therapeutics Inc , Vifor Pharma Group , European Union , National Registry Study , Swiss Stock Exchange , European Commission , Swiss Exchange , Exchange Commission , European Medicines Agency , Fresenius Medical Care , Regulatory News , Fresenius Medical Care Renal Pharma , Cara Therapeutics , Chief Medical Officer , Chief Executive Officer , Cara Therapeutic , Pharma Group , Sanifit Therapeutics , Vifor Fresenius Medical Care Renal Pharma , Chronic Kidney Disease Associated Pruritus , Registry Study ,

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

By Joshua Kirby

Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia s CSL Ltd. that values the company at $11.7 billion.

At 0812 GMT,. | December 14, 2021 ....

Vifor Pharma , Joshua Kirby , Dow Jones , Vifor Pharma Ag Stock Exchange , Press Release , 812 Vifn Ch0364749348 ,

Vifor Pharma shares jump 15% as takeover talks with CSL confirmed

Vifor Pharma s shares
surged more than 15% in early trading on Monday after
the Swiss drugmaker and Australia s CSL both confirmed
they were talking about a potential merger.
Australian. | December 13, 2021 ....

New South Wales , John Revill , Vifor Pharma , Shashwat Awasthi , Sameer Manekar , Richard Pullin , Subhranshu Sahu , Byron Kaye , Susan Fenton , Astrazeneca Plc , Vifor Pharma Ag Stock Exchange , Press Release , Otential Vifn Ch0364749348 ,